Data Characteristics
Pharmacovigilance data in regulatory affairs originates from clinical trial reports, non-clinical safety evaluation reports, post-marketing adverse event (AE) reports, drug labels, Risk Management Plans (RMP), and safety updates from global regulatory agencies. This data exists as structured documents (e.g., XML, tables in PDFs) and unstructured text (e.g., descriptive text in Word, PDFs). Clinical trial data is submitted once after trial completion. Post-marketing safety data is continuously collected and updated, with frequencies ranging from weekly to monthly. Report structures typically include patient demographics, adverse event descriptions, drug usage, and causality assessments. Adverse event descriptions often contain medical terminology, abbreviations, and dosage units. Terminology can be inconsistent across different data sources.
Constraints on Citation and Traceability
Diverse data sources and varying update frequencies impose specific requirements on citation and traceability. One-time submissions, like clinical trial reports, require citations to prioritize content completeness and authority. This ensures accurate recall of all critical safety information. Continuous updates of post-marketing adverse event reports require the system to handle incremental data. Citation results must reflect the latest safety status and avoid outdated information. Complex medical terminology, abbreviations, and inconsistent terminology across sources challenge precise matching and understanding. This necessitates more refined text processing strategies. Accurate traceability of critical fields, such as causality assessments, is vital for regulatory decisions. Citations must link to the original text, down to specific paragraphs or even table cells. These constraints collectively dictate that citation and traceability configurations must balance timeliness, precision, and completeness.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 500–800 characters | Balances contextual completeness of adverse event descriptions with retrieval efficiency. Avoids diluting key information in overly long segments. |
Recall count (Recall Count) | 8–12 items | Ensures coverage of multi-source information. Increased recall helps comprehensiveness, as adverse event reports may involve multiple related factors. |
Similarity threshold (Similarity Threshold) | 0.7–0.8 | Addresses diverse medical terminology and abbreviations. Ensures recall relevance while avoiding excessive irrelevant results. |
Rerank result count (Rerank Return Count) | 3–5 items | Further refines recall results. Improves precision and relevance of information presented to the user. |
Query Timeout | 600 seconds | Handles complex queries on large document collections, especially during comprehensive safety assessments. Ensures sufficient retrieval time. |
PARSE_FILE_TIMEOUT_SECONDS | 1200 seconds | Accommodates parsing large clinical trial reports or PDF documents. Ensures complete processing of file content. |
Common Pitfalls
- Empty or incomplete citation results: Caused by a
Similarity threshold(Similarity Threshold) set too high or aChunk size(Segment Length) set too short. This prevents effective matching of paragraphs with complex medical terms or fails to capture complete adverse event descriptions. - Citation results include outdated information: Caused by the knowledge base failing to synchronize the latest updates of post-marketing adverse event reports, or retrieval strategies not prioritizing the newest data.
- Slow retrieval speed or timeouts: Caused by
Recall count(Recall Count) orRerank result count(Rerank Return Count) being set too high, or a lack of effective index optimization for the knowledge base, leading to excessive query load.
Validation Steps
- Select a batch of regulatory submission documents containing known adverse events. Verify that citation results accurately point to adverse event descriptions, dosage information, and causality assessment paragraphs in the original text. Check the
Relevancescore. - Simulate post-marketing adverse event queries submitted at different times. Confirm that citation results prioritize the latest safety update documents. Check the document's
Update Timefield. - Monitor
Query Timeoutunder queries of varying complexity to ensure it stays within the preset range. Check logs forPARSE_FILE_ERRORorRETRIEVAL_TIMEOUTerrors. - Randomly sample citation results and cross-reference them with the original text. Ensure the accuracy and completeness of cited content, paying special attention to the correct parsing of medical terminology and abbreviations.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.